-
1
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
Published 2024-09-01“…Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. …”
Get full text
Article -
2
The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
Published 2025-01-01Get full text
Article -
3
Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
Published 2010-01-01“…The prognosis of epithelial ovarian cancer (EOC), the primary cause of death from gynaecological malignancies, has only modestly improved over the last decades. …”
Get full text
Article -
4
The Impact of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Epithelial Ovarian Cancer
Published 2022-12-01Subjects: “…Epithelial ovarian cancer, Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Prognostic factor, Systemic inflammatory response markers…”
Get full text
Article -
5
Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
Published 2012-01-01“…Epithelial ovarian cancer (EOC) continues to represent one of the most lethal conditions in women in the western countries. …”
Get full text
Article -
6
Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian Cancer
Published 2016-01-01“…The purpose of the present study was to analyze the predictive and prognostic role of soluble (pro)renin receptor (sPRR) as a biomarker for clinicopathological outcome in patients with primary epithelial ovarian cancer (EOC). As part of the renin-angiotensin system (RAS) whose activity is known to increase in ovarian cancer patients, the relation of sPRR and ovarian cancer should be further investigated. …”
Get full text
Article -
7
Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
Published 2025-01-01Subjects: “…Epithelial ovarian cancer…”
Get full text
Article -
8
Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancer.
Published 2025-01-01“…<h4>Objectives</h4>Epithelial ovarian cancer is a significant contributor to cancer-related mortality in women, frequently recurring post-treatment, often accompanied by chemotherapy resistance. …”
Get full text
Article -
9
Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
Published 2021-01-01Get full text
Article -
10
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis
Published 2025-01-01Subjects: “…epithelial ovarian cancer…”
Get full text
Article -
11
-
12
Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
Published 2023-04-01Subjects: Get full text
Article -
13
Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment
Published 2025-02-01Subjects: Get full text
Article -
14
Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues
Published 2009-01-01“…While semaphorins and their receptors appear to play a role in tumor carcinogenesis, little is known about the role of semaphorin 3F (S3F) in epithelial ovarian cancer (EOC) development. Therefore, we sought to determine the clinical relationship between S3F and its receptors, neuropilin-2 (NP-2) and neuropilin-1 (NP-1) with EOC progression. …”
Get full text
Article -
15
Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment
Published 2023-01-01“…The aim of this study was to explore prognostic factors, develop and internally validate a prognostic nomogram model, and predict the cancer-specific survival (CCS) of epithelial ovarian cancer (EOC) patients with pelvic exenteration (PE) treatment. …”
Get full text
Article -
16
Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
Published 2015-01-01“…Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). …”
Get full text
Article -
17
Development and validation of a nomogram to predict recurrence in epithelial ovarian cancer using complete blood count and lipid profiles
Published 2025-02-01Subjects: Get full text
Article -
18
Ultrasonic radiomics-based nomogram for preoperative prediction of residual tumor in advanced epithelial ovarian cancer: a multicenter retrospective study
Published 2025-02-01“…ObjectivesTo identify radiomic features extracted from ultrasound images and to develop and externally validate a comprehensive model that combines clinical data with ultrasound radiomics features to predict the residual tumor status in patients with advanced epithelial ovarian cancer (OC).MethodsThe study included 112 patients with advanced epithelial OC who underwent preoperative transvaginal ultrasound. …”
Get full text
Article -
19
KAT2B inhibits proliferation and invasion via inactivating TGF-β/Smad3 pathway-medicated autophagy and EMT in epithelial ovarian cancer
Published 2025-01-01Subjects: “…Epithelial ovarian cancer…”
Get full text
Article -
20
Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
Published 2025-02-01Subjects: “…epithelial ovarian cancer…”
Get full text
Article